Holen Sie sich die Stockscreener-App
0.1701
1.10%
-0.0019
Azitra Inc Aktie (AZTR) Neueste Nachrichten
Azitra to Present Corporate Update at Investment Conference - TipRanks
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra Inc (AZTR) Holds at $0.17 as Tight Range Between $0.16 Support and $0.18 Resistance PersistsFibonacci Extension - dars.gov.et
Azitra Inc (AZTR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Azitra (AZTR) Trading: Closes 13.25% Higher at $0.15; Immediate View: the Near-Term Reference Band Stretches From $0.14 to $0.16 under the Current SnapshotFibonacci Entry Signals - vinanet.vn
Azitra (AZTR) Levels: Finishes 4.81% Higher at $0.13 in the Current Update; Range Check - vinanet.vn
Azitra Regains NYSE American Listing Compliance Status - The Globe and Mail
Azitra (NYSE:AZTR) Strengthens Market Position After Listing Milestone - Kalkine Media
Branford bioscience firm regains NYSE compliance - Hartford Business Journal
Azitra regains compliance with NYSE American listing standards - Investing.com
Azitra regains compliance with NYSE American li... - Pluang
Azitra Regains NYSE American Compliance; .BC Indicator to Be Removed - TradingView
Azitra (NYSE: AZTR) wins back listing under new NYSE watch period - Stock Titan
Azitra regains compliance with NYSE American listing standards By Investing.com - Investing.com UK
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - PR Newswire
Azitra (AZTR) Earnings Comparison: The Bottom-Line Figure Trails Its Comparison in the Available Record; Post-Report Move: Shares Fall 7.61% in the Latest ReadingROA Comparison - vinanet.vn
Azitra (AZTR): Nantahala Capital reports 6.48M-share, 9.99% beneficial stake - Stock Titan
Nantahala Capital Partners (AZTR) discloses 8.40% beneficial stake in Azitra - Stock Titan
Azitra, Inc. (AZTR) stock price, news, quote and history - Yahoo Finance Australia
Azitra Reports Q2 Net Loss of $3.3 Million - Quiver Quantitative
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PR Newswire
Azitra (NYSE American: AZTR) posts Q2 2026 loss but lifts equity above NYSE limits - Stock Titan
Azitra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Azitra reports Q2 2026 results, advances skin t... - Pluang
Azitra Inc (AZTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AZTR Q1 2026 Earnings: EPS Misses Estimates Sharply; No Revenue ReportedProfitability Analysis - vinanet.vn
Azitra Inc (AZTR) Stock News Today - TradingKey
AZTR|Azitra Inc|Price:0.133|Chg%:+0.002 - TradingKey
Azitra Inc Q1 2026 Earnings: Deep EPS Miss Raises Concern as Revenue Remains AbsentBalance Sheet Strength - vinanet.vn
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar - TipRanks
AZTR Q1 2026 Earnings: Clinical-stage biotech posts wider-than-expected loss, shares declineRevenue Growth Report - vinanet.vn
Azitra Inc (AZTR) Income Statement - TradingKey
Azitra Inc Revenue Breakdown – AMEX:AZTR - TradingView
Azitra Inc (AZTR) Cash Flow - TradingKey
AZTR|Azitra Inc|Price:0.130|Chg%:+0.003 - TradingKey
Azitra Inc (AZTR) Balance Sheet - tradingkey.com
Azitra Inc (AZTR) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Azitra Inc (AZTR) Institutional Confidence - TradingKey
Azitra Inc (AZTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Azitra Inc (AZTR) Tests Key Support at $0.12 After Modest DeclineRSI Overbought Alerts - dars.gov.et
Azitra Inc (AZTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Azitra Inc (AZTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Azitra Inc (AZTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Azitra Inc (AZTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Azitra Inc (AZTR) Earnings Date & Reports & Earnings News - TradingKey
AZTR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Development Costs WeighGrowth Acceleration Report - vinanet.vn
AZTR Q1 2026 Earnings: Massive EPS Miss as Clinical-Stage Biotech Reports Wider LossAnnual Financial Report - vinanet.vn
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
Enterprise value to EBIT forward of Azitra Inc – AMEX:AZTR - TradingView
Price to sales forward of Azitra Inc – AMEX:AZTR - TradingView
Why are shares of Azitra rising? - MSN
Azitra Inc (AZTR) Retreats 6.85% as Stock Tests Key Support at $0.13Volume Breakout Ideas - dars.gov.et
Enterprise value to revenue forward of Azitra Inc – AMEX:AZTR - TradingView
Price to earnings forward of Azitra Inc – AMEX:AZTR - TradingView
AzitraAnnounces Breakthrough Ex Vivo Resul - Moomoo
Azitra, Inc. (NYSE American: AZTR) shows dose-linked skin elasticity gains - Stock Titan
/C O R R E C T I O N -- Azitra, Inc./ - AOL.com
Azitra's new skin treatment shows promise in im... - Pluang
AZTR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Shares DeclineProfit Growth Outlook - dars.gov.et
0.63%
3.49%
Kapitalisierung:
|
Volumen (24h):